scispace - formally typeset
C

Cláudia Henrique da Costa

Researcher at Rio de Janeiro State University

Publications -  80
Citations -  1012

Cláudia Henrique da Costa is an academic researcher from Rio de Janeiro State University. The author has contributed to research in topics: COPD & Medicine. The author has an hindex of 15, co-authored 73 publications receiving 789 citations. Previous affiliations of Cláudia Henrique da Costa include National Institutes of Health & Instituto Português de Oncologia Francisco Gentil.

Papers
More filters
Journal ArticleDOI

Obesity: systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function.

TL;DR: Weight loss caused by various types of treatment, including low-calorie diet, intragastric balloon, and bariatric surgery, significantly improves lung function and metabolic syndrome and reduces body mass index.
Journal ArticleDOI

CXCR3 and CCR5 chemokines in induced sputum from patients with COPD

TL;DR: CXCR3 chemokines and CCL5 are increased in sputum from COPD patients compared with nonsmokers, and may be important in COPD pathogenesis.
Journal ArticleDOI

Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD

TL;DR: Both monocytes and lymphocytes cooperate to enhance migration towards CXCR3 chemokines and CCL5, which may contribute to increased numbers of macrophages and T-cells in the lungs of COPD patients, and inhibition of recruitment using selective antagonists might be a treatment to reduce the inflammatory response in COPD.
Journal ArticleDOI

Sleep Apnea Clinical Score, Berlin Questionnaire, or Epworth Sleepiness Scale: which is the best obstructive sleep apnea predictor in patients with COPD?

TL;DR: SACS was better than BQ and ESS in predicting OSA in this group of patients with COPD, and this transversal study compared these three tests regarding their likelihood to predict OSA using receiver-operating characteristic curve statistics.
Journal ArticleDOI

Update on diagnosis and treatment of idiopathic pulmonary fibrosis

TL;DR: The current diagnostic criteria are listed and the therapeutic approaches currently available, symptomatic treatments, the action of new drugs that are effective in slowing the decline in pulmonary function, and indications for lung transplantation are described.